Accessibility Help | Sitemap | Contact Us | Customer Support Freephone 1 800 33 33 77
Ireland Change Country
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support
You are here: Home > News & Media > Corporate News
Print

News & Media

These press releases are intended as reference information for investors and journalists. The information contained in each press release was current at the time of issuance, and KCI assumes no responsibility for updating the information to reflect subsequent developments.

Top Stories

KCI, Leader in Advanced Wound Care Solutions KCI, LifeCell and Systagenix Combine to Form One Company and Rebrand as Acelity

Acelity is Industry Leading Medical Technology Company with $2 Billion in Revenue

KCI, Leader in Advanced Wound Care Solutions Novel KCI Skin Graft Harvesting Tool Now Available in Europe

CelluTome™ System takes autologous grafting out of the OR

Headlines

Displaying 1 to 10 of 110 News Items
3rd June 2014
New Study Reported Prevena™ Therapy Patients had a Significantly Lower Infection Rate Following Cardiac Surgery Compared to Control Group

Surgical incision management could generate savings of more than 60 million Euros in Germany alone

5th March 2014
Independent Study Shows V.A.C. VeraFlo™ Therapy More Beneficial Than Traditional V.A.C.® Therapy

Study Found Statistically Significant Reductions in OR Visits and Hospital Stay vs. Traditional V.A.C.® Therapy

14th January 2014
KCI Negative Pressure Wound Therapy with Instillation Supplement Published in International Wound Journal

Supplement Based on Presentations from the 2012 and 2013 International Surgical Wound Forums

8th January 2014
First International Consensus Guidelines Published for KCI Negative Pressure Wound Therapy with Instillation

Guidelines Published in Journal of Plastic and Reconstructive Surgery

11th November 2013
Growing Body of Evidence Supports V.A.C. VeraFlo™ Therapy Changing How Clinicians Approach Treating Wounds

Data Demonstrate Clinical and Economic Advantages of V.A.C. VeraFlo™ Therapy Compared to Traditional NPWT

28th October 2013
KCI Completes Acquisition of Systagenix

Peter Huntley Appointed Senior Vice President and Leader of Systagenix

26th August 2013
ABThera™ Open Abdomen Negative Pressure Therapy System Study Published in World Journal of Surgery

Significantly Improved Patient Outcomes Using ABThera™ Negative Pressure Therapy System in Open Abdomen Surgery

12th August 2013
KCI Introduces New V.A.C. VeraFlo™ Large Dressing

Taking Away the Large Burden of Wound Healing

30th July 2013
KCI to Acquire Systagenix

Strategic Transaction Strengthens KCI Leadership Position in Global Wound Care Market While Adding Diversification

Enhances Access to $3.4 Billion Advanced Wound Care Market, Leveraging KCI’s Well-Established Customer Relationships, Brand and Commercial Scale

Complementary Product Portfolio Will Advance Provision of Best-in-Class Solutions to Healthcare Professionals and Patients
 

Displaying 1 to 10 of 110 News Items

  • Share on Facebook.com
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Legal Notice | Privacy Policy | Contact Us


Copyright © 1998 – 2013 KCI Licensing, Inc All Rights Reserved.   DSL# 09-03-193.IE

The information included in this Web site has been prepared for and is intended for viewing exclusively within the Republic of Ireland. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications and restriction in different countries.